London Neurology Clinic

29/05/2026

🧠✨ A New Era in Neurology ✨🧠

Neurological disorders are now the leading cause of disability worldwide, with profound consequences for patients, caregivers, and health-care systems. As populations age, the global burden of neurological disease will rise substantially. Yet neurology has transformed over the past two decades. Adva...

03/05/2026

Gabapentinoids like gabapentin and pregabalin are associated with an increased risk for poisoning, with the highest risk occurring around treatment initiation and when combined with benzodiazepines or opioids.

In a large UK study of nearly 17,000 primary care patients, those who had co-initiation of gabapentinoids and benzodiazepines showed double the risk for hospitalization due to drug poisoning within the first month, whereas those with concomitant opioid use showed a 30% increased risk compared with those who took neither medication. https://mdsc.pe/4w6yUdZ

24/04/2026

London Neurology Clinic is proud to announce that it has been awarded the 2026 Neurology Practice Award by the American Academy of Neurology (AAN), presented at the AAN Annual Meeting in Chicago.

The award was accepted by Dr David Choluj, Medical Director of London Neurology Clinic.

This recognition is especially significant as London Neurology Clinic is the first clinic outside the United States to receive this prestigious honour. The American Academy of Neurology is the world’s largest professional organisation for neurologists, and its awards celebrate excellence, innovation, and leadership in neurological care on a global scale.

We extend our deepest thanks to our patients and our outstanding team — this achievement reflects our shared commitment to advancing the highest standards of neurological care.